The NPR1 gene (Natriuretic Peptide Receptor 1), also known as NPR-A or guanylate cyclase 1, encodes the major receptor for atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and C-type natriuretic peptide (CNP). This receptor is a member of the natriuretic peptide receptor family and functions as a particulate (membrane-bound) guanylate cyclase that catalyzes the conversion of GTP to cyclic GMP (cGMP) upon ligand binding. NPR1 is expressed throughout the cardiovascular system, kidney, adrenal gland, and importantly, in various brain regions where it plays roles in cardiovascular regulation, fluid homeostasis, memory formation, and neuroprotection. The NO-cGMP and natriuretic peptide-cGMP pathways represent parallel but distinct signaling cascades that converge on similar downstream effectors, making NPR1 an important nexus for understanding cardiovascular-neural interactions in neurodegeneration. [@kuhn2016]
Gene Information
<div class="infobox infobox-gene"> | Property | Value | |----------|-------| | Gene Symbol | NPR1 (NPR-A, GC-A) | | Full Name | Natriuretic Peptide Receptor 1 / Guanylate Cyclase 1 | | Chromosomal Location | 1q22 | | NCBI Gene ID | 4880 | | OMIM ID | 108012 | | Ensembl ID | ENSG00000118445 | | UniProt ID | P16066 | | Protein Class | Receptor guanylate cyclase | | Aliases | NPR1, NPRA, GC-A, ANPRA, Guanylate cyclase 1 | | Gene Family | Natriuretic peptide receptors (NPR1, NPR2/NPR-B, NPR3/NPR-C) | </div>
Protein Structure and Function
Structure
...
npr1
Introduction
The NPR1 gene (Natriuretic Peptide Receptor 1), also known as NPR-A or guanylate cyclase 1, encodes the major receptor for atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and C-type natriuretic peptide (CNP). This receptor is a member of the natriuretic peptide receptor family and functions as a particulate (membrane-bound) guanylate cyclase that catalyzes the conversion of GTP to cyclic GMP (cGMP) upon ligand binding. NPR1 is expressed throughout the cardiovascular system, kidney, adrenal gland, and importantly, in various brain regions where it plays roles in cardiovascular regulation, fluid homeostasis, memory formation, and neuroprotection. The NO-cGMP and natriuretic peptide-cGMP pathways represent parallel but distinct signaling cascades that converge on similar downstream effectors, making NPR1 an important nexus for understanding cardiovascular-neural interactions in neurodegeneration. [@kuhn2016]
Gene Information
<div class="infobox infobox-gene"> | Property | Value | |----------|-------| | Gene Symbol | NPR1 (NPR-A, GC-A) | | Full Name | Natriuretic Peptide Receptor 1 / Guanylate Cyclase 1 | | Chromosomal Location | 1q22 | | NCBI Gene ID | 4880 | | OMIM ID | 108012 | | Ensembl ID | ENSG00000118445 | | UniProt ID | P16066 | | Protein Class | Receptor guanylate cyclase | | Aliases | NPR1, NPRA, GC-A, ANPRA, Guanylate cyclase 1 | | Gene Family | Natriuretic peptide receptors (NPR1, NPR2/NPR-B, NPR3/NPR-C) | </div>
Protein Structure and Function
Structure
NPR1 is a single-pass transmembrane receptor (~1057 amino acids) with distinct structural domains:
Extracellular ligand-binding domain: N-terminal region that binds natriuretic peptides (ANP, BNP, CNP) with different affinities
Transmembrane domain: Single α-helix that anchors the receptor in the plasma membrane
Kinase-like domain: Intracellular domain with ATP-binding activity that regulates the guanylate cyclase domain
Guanylate cyclase domain: C-terminal catalytic domain that produces cGMP from GTP
The extracellular domain shows highest affinity for ANP, followed by BNP, with CNP binding at lower affinity. The intracellular domain exists in an autoinhibited state in the absence of ligand, with ATP binding to the kinase-like domain enhancing ligand-mediated activation. [@potter2011]
Activation Mechanism
NPR1 activation follows a ligand-binding-induced conformational change:
Ligand binding: ANP, BNP, or CNP binds to the extracellular domain
Conformational change: Ligand binding transmits a conformational change across the transmembrane domain
Kinase domain activation: The intracellular kinase-like domain undergoes a structural change
Cyclase activation: The guanylate cyclase domain becomes catalytically active
cGMP production: GTP is converted to cGMP, initiating downstream signaling
The kinase-like domain plays a regulatory role, with ATP acting as a positive allosteric modulator that enhances ligand-dependent cGMP production.
Function
NPR1-mediated cGMP production regulates multiple downstream effectors:
cGMP-dependent protein kinases (PKG): PKG I and II phosphorylate various targets
cGMP-regulated phosphodiesterases: Particularly PDE2 and PDE3
cGMP-gated ion channels: Regulate calcium homeostasis
Transcription factors: cGMP modulates gene expression through PKG and CREB
Expression Pattern
Brain Expression
NPR1 is expressed in multiple brain regions:
Hypothalamus: High expression in the supraoptic nucleus and paraventricular nucleus (regulating fluid balance)
Thalamus: Moderate expression in various thalamic nuclei
Circumventricular organs: High expression in areas lacking blood-brain barrier (organum vasculosum, subfornical organ)
Hippocampus: Expression in CA1 and CA3 regions, dentate gyrus
Cerebral cortex: Layer-specific expression in pyramidal neurons
Cerebellum: Purkinje cell expression
Brainstem: Expression in cardiovascular control centers
Peripheral Expression
Vascular system: Endothelial cells and vascular smooth muscle
Heart: Atrial and ventricular myocytes
Kidney: Glomerular mesangial cells, tubular cells
Adrenal gland: Adrenal cortex (zona glomerulosa)
Lung: Alveolar epithelial cells
Expression is modulated by physiological conditions, with increased expression during heart failure and certain neurological conditions. [@yamamoto2019]
Role in Neurodegeneration
Alzheimer's Disease
NPR1 and natriuretic peptides are increasingly recognized in AD pathogenesis:
ANP alterations: Atrial natriuretic peptide levels are altered in AD patients, with some studies showing decreased ANP in cerebrospinal fluid. The peptide has protective effects against Aβ toxicity through cGMP-dependent mechanisms. [@abdulle2013]
Amyloid-β interactions: ANP can protect neurons against Aβ-induced toxicity through NPR1-mediated cGMP signaling. This involves activation of PKG, which phosphorylates targets that reduce oxidative stress and apoptosis. [@chang2017]
Neurovascular function: NPR1 in endothelial cells regulates cerebral blood flow. Dysregulated natriuretic peptide signaling contributes to neurovascular dysfunction in AD.
Memory and synaptic function: cGMP signaling through NPR1 is involved in memory consolidation and synaptic plasticity. NPR1 activation can enhance long-term potentiation (LTP).
Tau pathology: Preliminary evidence suggests natriuretic peptide signaling may interact with tau phosphorylation pathways through cGMP-dependent kinases.
[@takamura2017] demonstrated that ANP can ameliorate memory deficits in animal models of AD through NPR1-mediated mechanisms.
Parkinson's Disease
NPR1 signaling is relevant to PD through several mechanisms:
Dopaminergic neuron survival: NPR1 is expressed in [dopaminergic neurons](/cell-types/dopaminergic-neurons) and activation can protect against dopaminergic toxicity. cGMP-mediated signaling has neuroprotective effects in PD models. [@morris2020]
Neuroinflammation: Natriuretic peptide signaling has anti-inflammatory effects, potentially modulating the neuroinflammation central to PD progression.
Mitochondrial function: NPR1-cGMP signaling modulates mitochondrial function and can protect against oxidative stress, a key factor in PD pathogenesis.
Blood-brain barrier: NPR1 in endothelial cells regulates BBB function, potentially affecting drug delivery and disease progression.
[@ogawa2021] demonstrated NPR1 expression in dopaminergic neurons and its role in neuroprotection.
Stroke and Cerebral Ischemia
NPR1 activation has protective effects in stroke:
Ischemic injury: NPR1 activation reduces infarct size and improves functional recovery in experimental stroke models